Witnesses´ profiles

Hans Henrik Kristensen
Medical director, head of regulatory affairs, medical affairs, and scientific communication at AJ Vaccines. Denmark.

• Principal investigator, senior author of the initial Plectasin paper and head of the department for the Plectasin project.

Per Holse Mygind
Director of immunogenicity & biomarkers at Ascendis Pharma A/S. Denmark.

• Researcher and first author of the initial Plectasin paper.

Kirk M. Schnorr
Senior science manager at Novozymes A/S since 2010. Denmark.

• Molecular biologist, discovered Plectasin in modified EST approach called "Signal trapping".

Olivier Taboureau
Professor of bioinformatics and biostatistics at Université Paris Cité and associate professor at the Technical University of Denmark.

• Postdoc and co-author in the initial Plectasin paper

Leonardo De Maria
Principal scientist at AstraZeneca, in Gothenburg, Sweden.

• Researcher and co-author in the initial Plectasin paper

Dorotea Raventos
Microbiologist. Recombinant studies. Science Manager at Novozymes, Denmark.

• Microbiologist and co-author of Plectasin papers.

Eefjan Breukink
Professor in membrane biochemistry & biophysics. Utrecht University, The Netherlands.

• Principal investigator for Plectasin’s new projects, funded by the EU.

Hans-Georg Sahl
Emeritus professor of medical and pharmaceutical microbiology at the University of Bonn, Germany.

• Active cooperator partner in the Plectasin project.